Unknown

Dataset Information

0

Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function.


ABSTRACT: Chimeric antigen receptors (CARs) link an antigen recognition domain to intracellular signaling domains to redirect T cell specificity and function. T cells expressing CARs with CD28/CD3? or 4-1BB/CD3? signaling domains are effective at treating refractory B cell malignancies but exhibit differences in effector function, clinical efficacy, and toxicity that are assumed to result from the activation of divergent signaling cascades. We analyzed stimulation-induced phosphorylation events in primary human CD8+ CD28/CD3? and 4-1BB/CD3? CAR T cells by mass spectrometry and found that both CAR constructs activated similar signaling intermediates. Stimulation of CD28/CD3? CARs activated faster and larger-magnitude changes in protein phosphorylation, which correlated with an effector T cell-like phenotype and function. In contrast, 4-1BB/CD3? CAR T cells preferentially expressed T cell memory-associated genes and exhibited sustained antitumor activity against established tumors in vivo. Mutagenesis of the CAR CD28 signaling domain demonstrated that the increased CD28/CD3? CAR signal intensity was partly related to constitutive association of Lck with this domain in CAR complexes. Our data show that CAR signaling pathways cannot be predicted solely by the domains used to construct the receptor and that signal strength is a key determinant of T cell fate. Thus, tailoring CAR design based on signal strength may lead to improved clinical efficacy and reduced toxicity.

SUBMITTER: Salter AI 

PROVIDER: S-EPMC6186424 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function.

Salter Alexander I AI   Ivey Richard G RG   Kennedy Jacob J JJ   Voillet Valentin V   Rajan Anusha A   Alderman Eva J EJ   Voytovich Uliana J UJ   Lin Chenwei C   Sommermeyer Daniel D   Liu Lingfeng L   Whiteaker Jeffrey R JR   Gottardo Raphael R   Paulovich Amanda G AG   Riddell Stanley R SR  

Science signaling 20180821 544


Chimeric antigen receptors (CARs) link an antigen recognition domain to intracellular signaling domains to redirect T cell specificity and function. T cells expressing CARs with CD28/CD3ζ or 4-1BB/CD3ζ signaling domains are effective at treating refractory B cell malignancies but exhibit differences in effector function, clinical efficacy, and toxicity that are assumed to result from the activation of divergent signaling cascades. We analyzed stimulation-induced phosphorylation events in primary  ...[more]

Similar Datasets

2018-08-13 | PXD007921 | Pride
| S-EPMC6676485 | biostudies-literature
| S-EPMC10275707 | biostudies-literature
| S-EPMC2840509 | biostudies-literature
| S-EPMC4528959 | biostudies-literature
| S-EPMC2932563 | biostudies-literature
| S-EPMC2727709 | biostudies-literature
| S-EPMC8100677 | biostudies-literature
| S-EPMC6539725 | biostudies-literature
| S-EPMC4040611 | biostudies-literature